VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CTNM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CTNMContineum Therapeutics, Inc.
$9.24$345M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCTNMPrice Target
CTNM logo

Contineum Therapeutics, Inc. (CTNM) Price Target Analysis

Updated Nov 6, 2026
Analyst Rating: Buy
Based on 4 analysts

112.9% Below Target

CTNM trades 112.9% below Wall Street's consensus target of $19.67.

Current Price$9.24
Average Target$19.67
Target
Current
Low$17.00
Median$19.00
High$23.00

Analyst Target Range

Forward P/E—
PEG Ratio—
Implied Growth-5.4%
(Declining)
Analyst Spread30.5%
(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$9.24
Consensus$19.67
High$23.00
Low$17.00

Consensus Scenario Assumptions

The base valuation assumes CTNM achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 4 published analyst recommendations for CTNM

50% hold / mixed conviction
+25
BearishBullish
Weighted analyst sentiment score based on 4 ratings
ConsensusBuy
Coverage4 Analysts
Net Score+25
Bull / Bear50% / 0%
Strong Buy00%
Buy250%
Hold250%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
250%
Hold
250%
Sell
00%
Strong Sell
00%
Recommendation Mix50% Buy · 50% Hold · 0% Sell
Buy (2)Hold (2)Sell (0)

CTNM Price Target Analysis

Updated November 19, 2026

As of November 19, 2026, Contineum Therapeutics, Inc. (CTNM) has a Wall Street consensus price target of $19.67, based on estimates from 4 covering analysts. With the stock currently trading at $9.24, this represents a potential upside of +112.9%. The company has a market capitalization of $345M.

Analyst price targets range from a low of $17.00 to a high of $23.00, representing a 31% spread in expectations. The median target of $19.00 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, CTNM trades at a trailing P/E of -5.6x. Analysts expect EPS to grow -5.4% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+66.4%
Industry Consensus
Avg Forward P/E
37.9x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
IMVT logo
IMVTImmunovant, Inc.
$6.8B$33.17$40.00
+20.6%
Buy—23
PRTA logo
PRTAProthena Corporation plc
$437M$8.35$30.00
+259.3%
Buy70.4x28
ARQT logo
ARQTArcutis Biotherapeutics, Inc.
$3.5B$27.61$41.80
+51.4%
Buy66.9x12
KYMR logo
KYMRKymera Therapeutics, Inc.
$10.0B$121.13$141.53
+16.8%
Buy—27
ACAD logo
ACADACADIA Pharmaceuticals Inc.
$3.1B$17.83$30.05
+68.5%
Buy28.6x37
INVA logo
INVAInnoviva, Inc.
$1.4B$18.40$38.00
+106.5%
Buy7.6x11
PTGX logo
PTGXProtagonist Therapeutics, Inc.
$8.2B$127.16$177.25
+39.4%
Buy27.1x26
RXRX logo
RXRXRecursion Pharmaceuticals, Inc.
$1.5B$2.83$5.90
+108.8%
Hold—10
CRL logo
CRLCharles River Laboratories International, Inc.
$16.1B$333.25$308.36
-7.5%
Buy29.3x37
MEDP logo
MEDPMedpace Holdings, Inc.
$18.1B$646.87$646.90
+0.0%
Hold35.5x19

CTNM — Frequently Asked Questions

Quick answers to the most common questions about buying CTNM stock.

What is the CTNM stock price target for 2026?

The consensus Wall Street price target for CTNM is $19.67, representing 112.9% upside from the current price of $9.24. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is CTNM a buy, sell, or hold?

CTNM has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $19.67 implies 112.9% upside from current levels.

Is CTNM stock overvalued or undervalued?

CTNM's current price is $9.24 with a consensus target of $19.67 (112.9% implied move). Analyst estimates suggest the stock is undervalued at current levels.

How high can CTNM stock go?

The most bullish Wall Street analyst has a price target of $23 for CTNM, while the most conservative target is $17. The consensus of $19.67 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover CTNM stock?

CTNM is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the CTNM stock forecast?

The 12-month CTNM stock forecast based on 4 Wall Street analysts shows a consensus price target of $19.67, with estimates ranging from $17 (bear case) to $23 (bull case). The median consensus rating is "Buy".

Should I buy CTNM stock?

Wall Street analysts are very optimistic on CTNM, with a "Buy" consensus rating and $19.67 price target (112.9% upside). 2 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do CTNM price targets vary so much?

CTNM analyst price targets range from $17 to $23, a 31% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $19.67 consensus represents the middle ground.

Consensus & Technical Research Suite
Open CTNM Terminal

CTNM Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare